Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.78 |
| ▸ | RECQL | P46063 | 1/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | CA2 | P00918 | 8/20 | 0.59 |
| ▸ | CA1 | P00915 | 7/20 | 0.59 |
| ▸ | CA12 | O43570 | 5/20 | 0.59 |
| ▸ | CA9 | Q16790 | 4/20 | 0.59 |
| ▸ | CA3 | P07451 | 3/20 | 0.59 |
| ▸ | CA4 | P22748 | 3/20 | 0.59 |
| ▸ | CA6 | P23280 | 3/20 | 0.59 |
| ▸ | CA5A | P35218 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 3/20 | 0.59 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL177790 | 0.88 | ALDH1A1 (1.00) | ALDH1A1RECQLHSD17B10KMT2ACA2 | |
| SCHEMBL27803677 | 0.86 | ALDH1A1 (0.95) | ALDH1A1RECQLHSD17B10KMT2ACA2 | |
| Hydrochloric Acid SCHEMBL5198585 | 0.86 | ALDH1A1 (0.95) | ALDH1A1RECQLHSD17B10KMT2ACA2 | |
| Benzene SCHEMBL27915918 | 0.84 | ALDH1A1 (0.91) | ALDH1A1RECQLHSD17B10KMT2ACA2 | |
| Methyl Alcohol SCHEMBL27669635 | 0.84 | ALDH1A1 (0.91) | ALDH1A1RECQLHSD17B10KMT2ACA2 | |
| SCHEMBL8418962 | 0.84 | CA12 (0.67) | ALDH1A1RECQLHSD17B10KMT2ACA2 | |
| SCHEMBL11419996 | 0.84 | CA2 (0.67) | ALDH1A1HSD17B10KMT2ACA2CA1 | |
| SCHEMBL11855965 | 0.84 | CA2 (0.67) | ALDH1A1HSD17B10KMT2ACA2CA1 | |
| SCHEMBL3158508 | 0.84 | CA2 (0.67) | ALDH1A1HSD17B10KMT2ACA2CA1 | |
| SCHEMBL9139800 | 0.82 | ALDH1A1 (0.88) | ALDH1A1RECQLHSD17B10KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7625917-B2 | S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein | TURPIN JAMES A | 2009-12-01 | — | — | US | disclosed |
| EP-1087941-B9 | THIOLESTERS AND USES THEREOF | US HEALTH (US) | 2007-11-07 | — | — | EP | disclosed |
| EP-1087941-B1 | THIOLESTERS AND USES THEREOF | US HEALTH (US) | 2006-08-16 | — | — | EP | disclosed |
| US-20040132785-A1 | Thiolesters and uses thereof | The Government of the U. S.of America as Represented by The Sec. of Health and Human Svc. (US) | 2004-07-08 | — | — | US | disclosed |
| US-6706729-B1 | A METHOD FOR DISSOCIATING A METAL ION FROM A ZINC FINGER-CONTAINING PROTEIN; INHIBITING VIRUS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-03-16 | — | — | US | disclosed |
| EP-1087941-A2 | THIOLESTERS AND USES THEREOF | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999065871-A2 | THIOLESTERS AND USES THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-12-23 | — | — | WO | disclosed |
| US-5464912-A | Adduct with rodlike mesogenic moiety, adduct made by reacting polyepoxide with nitro/so/ compound having epoxy-reactive hydrogen; conversion of hydroxyl product to ether, ester, halide, urethane, ketone, alkane; reducing nitro/so/ to amine | THE DOW CHEMICAL COMPANY (US) | 1995-11-07 | — | — | US | disclosed |
| US-5412044-A | Nitro group terminated mesogenic epoxy resin adducts | THE DOW CHEMICAL COMPANY (US) | 1995-05-02 | — | — | US | disclosed |
| US-5344898-A | Curable composition with stilbene groups and molecular orientation | THE DOW CHEMICAL COMPANY (US) | 1994-09-06 | — | — | US | disclosed |
| US-5298575-A | Consists of at least one compound having more than one vicinal epoxide group and at least one amine terminated adduct containing one or more mesogenic moities | THE DOW CHEMICAL COMPANY (US) | 1994-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132785-A1 | Thiolesters and uses thereof | SARS1, HAVCR2, P4HB | ALDH1A1 552/4885RECQL 2542/4885HSD17B10 694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.